Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News GlobeImmune Inc GBIM

Healthcare Biotechnology
GlobeImmune Inc. is a biopharmaceutical company. The Company is focused on developing products for the treatment of cancer and infectious diseases based on its Tarmogen platform. The Company’s Tarmogen platform activates the immune system by stimulating a subset of white blood cells called T cells that destroy infected or malignant cells in contrast to traditional vaccines, which predominately... see more

Recent & Breaking News (GREY:GBIM)

GlobeImmune Announces Updates

MarketWire Canada November 17, 2016

Mid-Afternoon Market Update: Crude Oil Up 2%; Supercom Shares Drop After Q1 Results

Benzinga.com  July 6, 2016

Mid-Day Market Update: U.S. Stocks Turn Positive; Nortek Shares Surge Following Acquisition News

Benzinga.com  July 6, 2016

12 Stocks Moving In Wednesday's Pre-Market Session

Benzinga.com  July 6, 2016

GlobeImmune Announces Delisting and Deregistration of Common Stock

MarketWire Canada July 5, 2016

Inovalis Real Estate Investment Trust Announces $40 Million Bought Deal Financing

MarketWire Canada July 5, 2016

6 Biggest Mid-Day Losers For Monday

Benzinga.com  June 20, 2016

8 Biggest Mid-Day Gainers For Monday

Benzinga.com  June 13, 2016

GlobeImmune Announces Updates and Financial Results for First Quarter 2016

MarketWire Canada May 12, 2016

Nanotech Security to Supply Security Feature for Major New Banknote

MarketWire Canada May 12, 2016

GlobeImmune Announces Updates and Financial Results for Full Year 2015

Marketwired March 16, 2016

Best Stocks to Buy for March 2016, If You So Choose

Accesswire March 11, 2016

GlobeImmune Announces Third Quarter 2015 Results and Corporate Highlights

Marketwired November 13, 2015

GlobeImmune Announces Second Quarter 2015 Results and Corporate Highlights

Marketwired August 14, 2015

GlobeImmune Engages Cantor Fitzgerald as Financial Advisor to Assist With Evaluation of Strategic Options

Marketwired August 13, 2015

Investigation of GlobeImmune, Inc. Announced by Glancy Prongay & Murray LLP

Business Wire June 10, 2015

GlobeImmune Announces Evaluation of Strategic Alternatives and Corporate Restructuring

Marketwired June 10, 2015

GlobeImmune Announces Top Line Results From GS-4774 Phase 2 Trial in Virally-Suppressed Chronic HBV Patients

Marketwired May 27, 2015

GlobeImmune Announces First Quarter 2015 Results and Corporate Highlights

Marketwired May 14, 2015

GlobeImmune Announces Opening of Randomized Phase 2 Chordoma Trial at National Cancer Institute

Marketwired April 22, 2015